JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice TargetHot
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $105 to $120.
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $105 to $120.